A progress report on the cutting-edge research into Alzheimer’s Disease and other forms of dementia, this important volume has particular emphasis on topics that are applicable to clinical practice.
In this latest instalment, Serge Gauthier, Philip Scheltens and Jeffrey Cummings cover some of the emerging therapies for Alzheimer’s Disease, including:
* GAG minetics
* the use of hormonal therapy and atypical anti-psychotic agents in the treatment of other related dementias.
Also summarizing current understanding of the pathophysiology of mild cognitive impairment, as well as research into tau pathologies, this is a key addition to literature in the area.
1. Neuropathology of MCI 2. CSF in AD and MCI 3. Executive Dysfunction in MCI and Alzheimer’s Disease 4. GAG Minetics in Alzheimer’s Disease 5. Immunotherapy for Alzheimer’s Disease 6. Statins for Alzheimer’s Disease 7. Insulin Resistance in Alzheimer’s Disease – A Novel Therapeutic Target 8. Atypical Antipsychotics in Dementia 9. Agitation in Dementia 10. Treatment of Vascular Risk Factors in Alzheimer's Disease 11. Cognitive Dysfunction in Multiple Sclerosis 12. Cholinesterase Inhibitors in Parkinson Disease Dementia 13. Modern Applications of EEG in Dementia Diagnosis